Skip to content

CAPRICOR THERAPEUTICS, INC.: 10-Q filed 2013-06-21

What CAPRICOR THERAPEUTICS, INC. reported in its quarterly report filed 2013-06-21 (fiscal Q3 2012): 29 published measures, 109 facts as tagged in accession 0001144204-13-036074.

This filing

Form
10-Q (quarterly report)
Filed
2013-06-21
Fiscal period
fiscal Q3 2012
Accession
0001144204-13-036074 on SEC EDGAR

Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All CAPRICOR THERAPEUTICS, INC. filings.

Reported measures

Total assets

Resources recognized on the balance sheet. Book assets are not the market value of the business.

PeriodValueUnitDays
At 2012-09-30495,225USD
At 2011-12-311,372,170USD

Total liabilities

Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.

PeriodValueUnitDays
At 2012-09-30467,993USD
At 2011-12-31541,447USD

Stockholders equity

The reported residual interest after liabilities. It is an accounting amount, not market capitalization.

PeriodValueUnitDays
At 2012-09-3027,232USD
At 2011-12-31830,723USD
At 2010-12-312,596,868USD
At 2009-12-312,982,150USD
At 2008-12-315,103,618USD
At 2007-12-3115,199,932USD
At 2006-12-31-2,576,515USD
At 2005-12-31-5,043USD

Cash and cash equivalents

Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.

PeriodValueUnitDays
At 2012-09-30282,507USD
At 2011-12-311,039,190USD
At 2011-09-302,607,336USD
At 2010-12-313,378,155USD
At 2005-07-310USD

Net income or loss

Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.

PeriodValueUnitDays
2012-07-01 to 2012-09-30-566,232USD92
2012-01-01 to 2012-09-30-1,691,045USD274
2005-08-01 to 2012-09-30-46,506,025USD2618
2011-01-01 to 2011-12-31-4,884,786USD365
2011-07-01 to 2011-09-30-1,144,073USD92
2011-01-01 to 2011-09-30-3,220,396USD273
2010-01-01 to 2010-12-31-6,031,491USD365
2009-01-01 to 2009-12-31-7,872,297USD365
2008-01-01 to 2008-12-31-13,131,596USD366
2007-01-01 to 2007-12-31-10,302,795USD365
2006-01-01 to 2006-12-31-2,581,972USD365
2005-08-01 to 2005-12-31-10,043USD153

Operating cash flow

Cash generated or used by operating activities. Working-capital timing can make this differ substantially from reported income.

PeriodValueUnitDays
2012-01-01 to 2012-09-30-1,950,890USD274
2005-08-01 to 2012-09-30-34,655,369USD2618
2011-01-01 to 2011-09-30-3,080,632USD273

Capital expenditure payments

Cash payments to acquire property, plant and equipment. This taxonomy concept does not capture every form of investment or acquisition.

PeriodValueUnitDays
2012-01-01 to 2012-09-300USD274
2005-08-01 to 2012-09-30130,855USD2618
2011-01-01 to 2011-09-300USD273

Revenue

Revenue under this specific accounting concept. A missing value is not zero; filers can use other revenue concepts.

PeriodValueUnitDays
2012-07-01 to 2012-09-300USD92
2012-01-01 to 2012-09-30195,500USD274
2005-08-01 to 2012-09-302,032,235USD2618
2011-07-01 to 2011-09-30813,000USD92
2011-01-01 to 2011-09-301,159,000USD273

Financing cash flow

Net cash from financing activities, including borrowing, repayments and transactions with owners. A positive amount does not establish operating profitability.

PeriodValueUnitDays
2012-01-01 to 2012-09-301,194,207USD274
2005-08-01 to 2012-09-3035,411,822USD2618
2011-01-01 to 2011-09-302,309,813USD273

Investing cash flow

Net cash from investing activities, including asset purchases, disposals and investment transactions. This differs from capital expenditure payments alone.

PeriodValueUnitDays
2012-01-01 to 2012-09-300USD274
2005-08-01 to 2012-09-30-473,946USD2618
2011-01-01 to 2011-09-300USD273

Retained earnings or deficit

Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.

PeriodValueUnitDays
At 2012-09-30-46,506,025USD
At 2011-12-31-44,814,980USD

Net property, plant and equipment

Carrying amount of property, plant and equipment after accumulated depreciation, depletion and amortization. It is not replacement cost or market value.

PeriodValueUnitDays
At 2012-09-304,938USD
At 2011-12-319,744USD

Share-based compensation expense

Reported noncash expense for share-based payment arrangements. Noncash treatment does not mean the awards have no economic cost to shareholders.

PeriodValueUnitDays
2012-01-01 to 2012-09-30305,243USD274
2005-08-01 to 2012-09-3010,610,703USD2618
2011-01-01 to 2011-09-30686,711USD273

Operating income or loss

Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.

PeriodValueUnitDays
2012-07-01 to 2012-09-30-576,312USD92
2012-01-01 to 2012-09-30-2,120,604USD274
2005-08-01 to 2012-09-30-46,605,920USD2618
2011-07-01 to 2011-09-30-1,156,364USD92
2011-01-01 to 2011-09-30-3,234,209USD273

Current assets

Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.

PeriodValueUnitDays
At 2012-09-30438,349USD
At 2011-12-311,310,488USD

Interest expense

Borrowing costs recognized as interest expense. This is distinct from cash interest paid and may not include every capitalized borrowing cost.

PeriodValueUnitDays
2012-07-01 to 2012-09-300USD92
2012-01-01 to 2012-09-300USD274
2005-08-01 to 2012-09-301,273,734USD2618
2011-07-01 to 2011-09-300USD92
2011-01-01 to 2011-09-300USD273

Current liabilities

Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.

PeriodValueUnitDays
At 2012-09-30287,143USD
At 2011-12-31541,447USD

Current accounts payable

Current amounts owed to suppliers for goods and services received. This is one component of current liabilities, not all accrued obligations.

PeriodValueUnitDays
At 2012-09-30210,050USD
At 2011-12-31437,837USD

Operating expenses

Recurring operating costs under this accounting concept, generally excluding production costs included in cost of sales. Check filing presentation before combining expense subtotals.

PeriodValueUnitDays
2012-07-01 to 2012-09-30576,312USD92
2012-01-01 to 2012-09-302,316,104USD274
2005-08-01 to 2012-09-3048,638,155USD2618
2011-07-01 to 2011-09-301,969,364USD92
2011-01-01 to 2011-09-304,393,209USD273

Research and development expense

Research and development costs recognized as expense. Capitalization policies and acquired projects can make this differ from total cash invested in development.

PeriodValueUnitDays
2012-07-01 to 2012-09-30179,142USD92
2012-01-01 to 2012-09-30976,945USD274
2005-08-01 to 2012-09-3030,972,836USD2618
2011-07-01 to 2011-09-301,470,091USD92
2011-01-01 to 2011-09-302,795,354USD273

Common shares outstanding

Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.

PeriodValueUnitDays
At 2012-09-3043,062,231shares
At 2011-12-3139,712,231shares

Additional paid-in capital

Capital contributed above par value under this concept. It records historical contributions, not the current value of the equity or cash on hand.

PeriodValueUnitDays
At 2012-09-3046,490,195USD
At 2011-12-3145,605,991USD

Prepaid expenses and other current assets

Prepayments and other current assets grouped under this concept. The balance is not cash and its composition differs by filer.

PeriodValueUnitDays
At 2012-09-30155,842USD
At 2011-12-31271,298USD

General and administrative expense

General and administrative costs reported under this concept, separate from selling expense. Filers group overhead differently, so compare presentation before comparing companies.

PeriodValueUnitDays
2012-07-01 to 2012-09-30397,170USD92
2012-01-01 to 2012-09-301,339,159USD274
2005-08-01 to 2012-09-3017,665,319USD2618
2011-07-01 to 2011-09-30499,273USD92
2011-01-01 to 2011-09-301,597,855USD273

Depreciation, depletion and amortization

Combined depreciation, depletion and amortization for the period. A noncash allocation of asset cost, not a measure of maintenance spending.

PeriodValueUnitDays
2012-01-01 to 2012-09-304,806USD274
2005-08-01 to 2012-09-30325,454USD2618
2011-01-01 to 2011-09-305,879USD273

Other nonoperating income or expense

Other income or expense outside operations under this concept. The composition is filer-specific and can include one-time items.

PeriodValueUnitDays
2012-07-01 to 2012-09-309,771USD92
2012-01-01 to 2012-09-30428,410USD274
2005-08-01 to 2012-09-30578,515USD2618
2011-07-01 to 2011-09-3010,411USD92
2011-01-01 to 2011-09-308,901USD273

Nonoperating income or expense

Total nonoperating income or expense, which can include interest, investment results and other items. A positive value is not operating profit.

PeriodValueUnitDays
2012-07-01 to 2012-09-3010,080USD92
2012-01-01 to 2012-09-30429,559USD274
2005-08-01 to 2012-09-3099,895USD2618
2011-07-01 to 2011-09-3012,291USD92
2011-01-01 to 2011-09-3013,813USD273

Proceeds from issuing common stock

Cash received from issuing common stock during the period. It is gross of costs only where the filer reports it so, and it does not include noncash issuances.

PeriodValueUnitDays
2012-01-01 to 2012-09-300USD274
2005-08-01 to 2012-09-305,000USD2618
2011-01-01 to 2011-09-300USD273

Change in accounts payable

The cash flow adjustment for the change in payables during the period. A positive value under this concept means payables grew and added to operating cash flow.

PeriodValueUnitDays
2012-01-01 to 2012-09-30-227,787USD274
2005-08-01 to 2012-09-30210,050USD2618
2011-01-01 to 2011-09-30171,953USD273

Inspect the source

Entity
CAPRICOR THERAPEUTICS, INC. / CIK 0001133869
Captured
2026-09-20T07:41:24.575Z
SEC response SHA-256
b9f947143784aa2a5b7cc0470638338f21bd5664475f1be49c554014f98dbf5c

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python
import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001133869.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))